GSOA
15.12.2021 17:35:10 CET | Business Wire | Press release
Chief Executives of the world’s leading satellite operators announced today in Paris on the occasion of World Satellite Business Week 2021 that ESOA, the EMEA Satellite Operators Association, is expanding to include satellite operators from all world regions and will change its name to GSOA, the Global Satellite Operators’ Association. They also announced that seven new members – Amazon, APT, ARSAT, Intersputnik, Lockheed Martin, Omnispace and Star One – had already agreed to join GSOA.
GSOA will remain the only CEO-driven satellite industry association. It will focus on a core mission of providing a unified voice and a platform for collaboration for satellite operators globally to ensure their continued success and for broadening the opportunities for policymakers and industry players to leverage satellite services to fulfil their objectives.
“The creation of GSOA reflects a strong belief in the satellite communications sector that a strong, global voice is needed to ensure that the sector is well positioned to helping create a more connected and sustainable world,” said Stephen Spengler, ESOA Chairman and CEO of Intelsat. “The fact that new members are already joining us is a demonstration of support for GSOA’s mission and the need to ensure that, together, we have a strong voice in shaping the communications ecosystem of the future.”
Leading Change
GSOA is structured to drive industry leadership in the face of three key trends: unparalleled innovation in the space sector, an insatiable demand for all types of connectivity, and a need to bring sustainability to space. In this regard, the GSOA Board has approved three broad industry goals.
GSOA is committed to:
On earth: extending connectivity globally where other networks don’t, connecting unconnected communities, schools, households, planes, ships, businesses, humanitarian agencies, peacekeepers and governments, aiming to increase the number of satellite data connections by 250% by 2030 and increase the data consumed by those connections 15 fold.
In space: preserving the space environment for future generations by designing, launching and operating satellites in a responsible way and minimising the creation of space debris.
For all: supporting the UN Sustainable Development Goals by providing access to secure, reliable and sustainable broadcast & broadband connectivity to people, schools, enterprises, organisations and devices wherever they may be, whether on the move, at work, or at play.
ESOA to GSOA
With the industry’s multi-orbit offering, the satellite sector will respond to the great majority of connectivity requirements presented by the data driven economy of tomorrow. From bridging crippling social, education, healthcare and other divides that exist due to the lack of communications infrastructure on all continents to enabling a host of 5G and IoT use cases for different vertical sectors.
Satellite operators will continue to build on the successes of ESOA which include providing the support the industry needed to push ahead with 5G standards and vital leadership on issues such as satellite spectrum and space sustainability. Through GSOA, the satellite sector will now be able to drive such global activities leveraging a global operator base.
GSOA will provide its members with the opportunity to shape the future of the satellite communications industry and the frameworks in which it operates by participating in key activities that impact the sector. Specifically, GSOA members will be able to engage in cross-sector initiatives, drive common positions, represent the industry on topics such as spectrum and 5G in events on all continents and contribute to ITU work concerning the development agenda, emergency communications and of course spectrum.
The association will continue to have a CEO-led Board, which has proved invaluable to the success of the ESOA to date, a strong Secretariat, and member-driven working groups that execute the broad agenda set by the Board.
“This is an important change that will help ensure the industry is positioned well into the future ”, said Aarti Holla-Maini, the secretary general of ESOA. “We also recognize that there are other industry associations who will want to understand the implications of this change and we look forward to working with them to ensure the satellite communications sector has the strongest possible, unified global voice .”
The Global Satellite Operators Association now counts among its members: Airbus CIS, Amazon, Amos Spacecom, APT, Arabsat, Arsat, Avanti, Azercosmos, Echostar-Hughes, HellasSat, Hispasat, Inmarsat, Intelsat, Intersputnik, Lockheed Martin, Nigcomsat, Nilesat, Omnispace, OneWeb, Rascomstar, SES, SSI-Monacosat, Star One, Telenor, Telesat, Telespazio, Thuraya, Turksat, Viasat and Yahsat as well as representatives of the broader space industry including Airbus Defence and Space, Arianespace, Astroscale, Mansat, ST Engineering and Thales Alenia Space.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211215005734/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Rapid Medical™’s TIGERTRIEVER™ 13 Demonstrates Promising 90-Day Outcomes in DISTALS Trial, Reinforcing Pivotal Safety and Efficacy Findings7.5.2026 14:03:00 CEST | Press release
Full data presented at ESOC 2026 further strengthen the clinical evidence supporting TIGERTRIEVER™ 13 for the treatment of distal vessel occlusion stroke — a segment representing nearly half of all ischemic strokes Rapid Medical™, a leading developer of advanced stroke treatment devices, today announced full results from the DISTALS randomized clinical trial, presented at the 11th European Stroke Organisation Conference (ESOC) in Maastricht, Netherlands, showing that TIGERTRIEVER™ 13 can safely restore blood flow to the brain and may improve clinical outcomes in patients with distal and medium vessel occlusion (DMVO) stroke. These findings build on earlier results showing a threefold improvement in restoring blood flow compared with medical management alone (p<0.0001), with no cases of serious brain bleeding observed in the treatment group. “These results show we can now safely restore blood flow and suggest this will make a meaningful difference for the right patients,” said Jeffrey L
2 Million Downloads in Six Months: Tabelog’s Multilingual App Solves Critical Dining Pain Points for Travelers to Japan7.5.2026 14:00:00 CEST | Press release
“Eat Where Locals Eat” Making authentic Japanese dining experiences accessible to global travelers through instant reservations at over 70,000 restaurants nationwide. Tabelog (https://tabelog.com/en/), one of Japan’s largest (*1) restaurant search and reservation services operated by Kakaku.com, Inc., has announced that its multilingual smartphone app (iOS/Android) for travelers visiting Japan has reached 2 million downloads (*2). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507560248/en/ 2M+ Downloads in 6 Months. The app also ranked #1 in downloads among Restaurant Search Apps in Japan for International Travelers (*3) in Taiwan, Hong Kong, South Korea, and the U.S., reflecting its immense popularity among global visitors. Download URL: https://tabelog-tourists.onelink.me/3eEh/iqkkho9r The Trusted Choice for Global Travelers: Solving Two Major Dining Pain Points in Japan For years, international visitors to Japan have
Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development7.5.2026 14:00:00 CEST | Press release
Altasciences, a fully integrated drug development solution company, andCertara (Nasdaq: CERT), a global leader in model-informed drug development (MIDD), today announced a strategic partnership to accelerate early-phase development programs. Fewer than half of preclinical drug candidates successfully reach first-in-human trials. Failures are driven by toxicity, poor pharmacokinetics, lack of efficacy, and challenges translating results from animals to humans. Many of these risks can be mitigated through a fully integrated model-informed drug development approach. Building on Altasciences’ Acceleration Platform, the integration of Certara’s strategic drug development services and biosimulation technology enables sponsors to establish proof of mechanism earlier, design more efficient studies, and make informed go/no-go decisions with greater confidence. By embedding modeling insights and digital workflows directly into development execution, study designs are optimized, dosing strategies
FIFA and Fanatics Expand Wide-Ranging Relationship to Include Historic Exclusive Collectibles Agreement (Trading Cards, Stickers and Trading Card Games)7.5.2026 13:00:00 CEST | Press release
Partnership includes FIFA tournaments and events from 2031Agreement encompasses both physical and digital collectibles, and for the first time brings the player jersey patch program to international footballPre-match press conferences for the FIFA World Cup Final to take place at Fanatics Fest on Friday, 17 July 2026 In a landmark agreement expanding their already successful wide-ranging commercial relationship, FIFA and Fanatics have signed a long-term, exclusive collectibles licensing deal that features trading cards, stickers, and trading card games. The agreement, which will begin in full in 2031, covers both physical and digital collectibles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507105628/en/ An example of the product innovations that will be brought to fans under this new partnership is the highly sought-after player jersey patch program, including debut patches, which will be inserted into football tradin
DEFINITIVE Trial Reaches Major Milestone: All Centres Approved and More Than 50% Recruitment Achieved7.5.2026 11:21:00 CEST | Press release
Poster presented at ESMO Breast Cancer 2026: Exploring health policy and real-world treatment strategies for early-stage HER2-positive breast cancer across Europe. The DEFINITIVE project, a landmark European Union-funded international phase III clinical trial evaluating the use of the HER2DX diagnostic assay to guide personalised treatment in early-stage HER2-positive breast cancer (BC), announces two major operational milestones at the ESMO Breast Cancer 2026 congress. Approvals have been obtained in the 7 participating countries, 33 clinicals sites are now open for patient recruitment. The trial has reached over 50% of its recruitment target, marking a pivotal moment on the path toward to transforming HER2-positive BC treatment. About the DEFINITIVE Project The DEFINITIVE project is a 5-year, prospective, open-label, randomised, two-arm phase III international clinical trial conducted across 44 centres in 7 European member states and associated countries. The trial aims to demonstrat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
